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Abstract Evidence supports the health promoting benefits of
berries, particularly with regard to the prevention and manage-
ment of chronic diseases such cardio- and cerebrovascular
disease, diabetes and Alzheimer’s disease. Two related patho-
physiological features common to many of these conditions are
oxidative stress and the accumulation of advanced glycation
endproducts (AGEs). Whereas antioxidant properties are well-
established in several species of berries and are believed central
to their protective mechanisms, few studies have investigated
the effects of berries on AGE formation. Here, employing a
series of complementary in vitro assays, we evaluated a collec-
tion of wild berry extracts for 1) inhibitory effects on
fluorescent-AGE and Nε- (carboxymethyl)lysine-albumin ad-
duct formation, 2) radical scavenging activity and 3) total
phenolic and anthocyanin content. All samples reduced AGE
formation in a concentration-dependent manner that correlated
positively with each extract’s total phenolic content and, to a
lesser degree, total anthocyanin content. Inhibition of AGE
formation was similarly related to radical scavenging activities.
Adding antiglycation activity to the list of established function-
al properties ascribed to berries and their phenolic metabolites,
our data provide further insight into the active compounds and
protective mechanisms through which berry consumption may
aid in the prevention and treatment of chronic diseases associ-
ated with AGE accumulation and toxicity. As widely available,
safe and nutritious foods, berries represent a promising dietary
intervention worthy of further investigation.
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Introduction
The potential benefits of fruit consumption to human health
have long been recognized. Recently, several berries1 have
emerged as excellent sources of phytonutrients with putative
protective effects toward age-related chronic diseases [1].
Promising evidence in human, animal and cellular studies
specifically links berry consumption to lower risk of cardiovas-
cular disease, diabetes and associated complications, cancer,
and neurodegenerative diseases [2–5]. In addition to providing
a valuable source of vitamins, minerals, and dietary fiber,
berries contain a diversity of secondary metabolites, most
notably phenolics, which show complex biological activity [6].
Berry phenolics range in structural complexity, from simple
phenolic acids to polyphenolic tannins. Although present in
many fruits, certain types of berries are remarkably rich in
phenolic metabolites – particularly anthocyanins [7]. Responsi-
ble for the red, blue and purple colours characteristic of many
1 In this paper, the term ‘berry’ is used in reference to small, soft fruits and
includes fruits such as raspberry and strawberry that, botanically, are not
true berries.
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berries, anthocyanins are extensively studied and often listed as
medicinal ingredients of berry-based health products. Beyond
antioxidant properties, berry phenolics (including anthocyanins)
display anti-inflammatory, cardioprotective, neuroprotective and
hypoglycemic activities through modulation of multiple signal-
ing pathways implicated in the development of chronic and
degenerative diseases [8–10]. Many phenolics also inhibit the
formation of advanced glycation endproducts (AGEs) [11].
The accumulation and ensuing physiological consequences
of AGEs often appear in patients with diabetes, cardiovascu-
lar, renal and neurodegenerative diseases as well as some
types of cancer [12,13]. Produced through non-enzymatic re-
actions between reducing sugars and proteins, nucleic acids, or
lipids, AGEs induce oxidative stress and molecular cross link-
ages that cause cellular and tissue damage by impairing protein
function and clearance [14]. Several AGEs, such as
Nε-(carboxymethyl)lysine (CML), activate the cell surface
AGE receptor (RAGE) to initiate NF-κB and associated proin-
flammatory signaling pathways [14,15]. Whereas AGEs are
produced endogenously under normal physiological conditions,
they accumulate with age, developing more readily in
hyperglycaemic and oxidative conditions. Despite the known
antioxidant activity of berries and antiglycation activity of relat-
ed phenolics, only few individual species have been assessed for
effects on AGE formation [16,17]. In these studies, phenolic
metabolites are consistently identified as active constituents [16].
Here, using complementary in vitro assays, we evaluate 12
species of wild berries collected from northern Québec, Canada,
for their effects on AGE formation. Predicting that antiglycation
activity will correlate positively with both phenolic content and
anti-oxidant activity, we also assess each extract for total phenolic
content, anthocyanin content and radical scavenging capacity.
Materials and Methods
Reagents Chemicals and solvents were purchased fromFisher
Scientific (Ottawa, ON, Canada) unless otherwise specified.
Plant Materials and Extraction Ripe berries and voucher
specimens were collected from various locations in Québec,
Canada. Upon maturity (August–September), samples were
harvested, cleaned, and frozen on site prior to transportation to
the University of Ottawa for extraction. Voucher specimens
were deposited in the University of Ottawa Herbarium in
Ottawa, Canada, with identities confirmed by Dr. Alain
Cuerrier. Twenty grams of frozen berries from each collection
were lyophilized to dryness, crushed with a mortar and pestle
then extracted three times with 25 mL of 80 % ethanol per g
dry material. Filtered extracts were pooled prior to drying
using a Speedvac System AE52010 (Savant, Halbrook, NY)
at 43 °C followed by lyophilization. Dried extracts were
stored at 4 °C in darkness.
AGE Formation Assay Effects on AGE formation were de-
termined as previously described [16]. Briefly, 100 mM sodi-
um phosphate monobasic monohydrate buffer (pH 7.4) with
100 mM glucose/100 mM fructose (BDH Chemicals Ltd.,
Toronto, ON) and bovine serum albumin (BSA) (Sigma Al-
drich, St. Louis, MO, USA) (1 mg/mL) were incubated with
vehicle (negative control), berry extract (treatment), or quer-
cetin (positive control) in darkness for seven days at 37 °C on
a mechanical shaker (Series 25 Incubator Shaker, New Bruns-
wick Scientific Co. Inc., Edison, NJ). Each plate included
positive and negative controls as well as replicates without
BSA to correct for analyte autofluorescence and without sugar
to: 1) control for non-AGE-derived fluorescence of BSA, and
2) serve as a negative control for immunochemical assessments.
Extracts were tested at concentrations of 12.5 – 400 μg/ml, in
quadruplicate, on at least three separate occasions.
Detection and Quantitation of Fluorescent AGEs and CML-
BSA Adducts Fluorescent AGEs were measured at excitation
and emission wavelengths of 355 and 460 nm, respectively,
using a SpectraMax M5 microplate reader (Molecular Devices,
Sunnyvale, California). After measurement, plates were sealed
with parafilm and stored at −20 °C for immunochemical analy-
ses. Percent inhibition was calculated with corrected fluores-
cence values (F): % inhibition=[(Fnegative−Fexperimental)/
(Fnegative)]×100 % [18]. IC50 concentrations, defined as the
amount of extract (μg/ml) or positive control (μM) required to
reduce AGE formation by 50 % relative to the negative control,
were determined by logarithmic regression analyses (n=3–4).
To detect and quantitate CML-BSA adduct formation [18],
samples from control and extract-treated wells were first con-
centrated using Ultracel YM-10 membrane centrifugal filters
(Millipore, Billerica, MA, USA). BSA concentrations were
established by Bio-Rad DC Protein assay Kit (Bio-Rad Labo-
ratories Ltd., Mississauga, ON, CAN). After protein separation
by SDS-PAGE under reducing conditions, Western blot analy-
ses were performed using mouse monoclonal antibodies
targeted against CML-BSA adducts (1:1000, Clone 318003,
R & D Systems, Minneapolis, MN, USA) and goat anti-mouse
IgG polyclonal antibodies conjugated with horseradish perox-
idase (1:1000, R & D Systems). Blots were treated with
SuperSignalWest Pico (MJSBioLynx Inc) to visualize adducts.
To qualitatively evaluate concentration-dependent effects,
protein samples treated with 25, 50, and 100 μg/mL of the
same extract were loaded on a single gel. Quantitative com-
parisons were conducted on blots of samples treated with
different extracts administered at 50 μg/mL. Gels stained with
Coomassie Blue and photographed following electrophoresis
served as loading controls. Immunoreactive and Coumassie
stained bands were quantified by image densitometry (ImageJ
software v.1.38X, National Institutes of Health, Bethesda,
MD). After correcting for protein loading, we calculated per-
cent inhibition relative to vehicle control (n=4–6).
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Measurement of Total Phenolic and Total Anthocyanin
Content Total phenolic content (TPH) was determined via a
modified Folin-Ciocalteau method [19]. Freshly diluted
Folin-Ciocalteau reagent (BDH, Toronto, ON) was com-
bined with extract re-solubilized in 80 % ethanol and,
after 5 min of equilibration, 7.5 % anhydrous NaHCO3
solution. After 2 h incubation at 23 °C, absorbance was
measured at 725 nm and TPH values were calculated
and expressed as quercetin (Sigma, Oakville, ON)
equivalents. Experiments were conducted in quadrupli-
cate on at least three separate occasions (n=3–4).
Total monomeric anthocyanin content (TMAC) was mea-
sured following the acid-differential method [20]. Duplicate
samples of each berry extract were dissolved in 0.025 M
potassium chloride buffer, one adjusted to pH 1.0 and the
other to pH 4.5 using 0.4 M sodium acetate buffer. After
15 min of incubation at RT, absorbance values at 496 and
700 nm were obtained with a Beckman DU-640 Spectropho-
tometer (Fullerton, CA). TMACwas calculated and expressed
as cyanidin-3-glucoside (Fluka, Lyon, France) equivalents
using corresponding molar absorptivity (26,900 L/cm·mol)
and molecular weight (449.2 g/mol). Experiments were con-
ducted in quadruplicate on three or more occasions (n=3–4).
Radical Scavenging Assays Oxygen radical absorbance ca-
pacity (ORAC) was measured as previously described [18] in
75 mM phosphate buffer solution (PBS), pH 7.0. Freshly
prepared vehicle (50 % MeOH/50 % PBS), Trolox (0.006-
12.5 μM), ascorbic acid (0.006-12.5 μM), quercetin (0.002-
3.13 μM) or berry extract (0.006-12.5 μg/mL) were loaded in
black 96-well microplates, mixed with 0.08 μM fluorescein
and allowed to incubate at 37 °C for 10 min before adding
150 mMAAPH. Fluorescence was monitored with a Synergy
HT Multi-detection microplate reader (BioTek Instruments,
Inc., Winooski, VT) every three min for 90 min at excitation
and emission wavelengths of 485 nm and 530 nm, respective-
ly. ORAC values were calculated as μM Trolox equivalents
per mg dried extract as determined from at least four separate
experiments (n=4–5).
A modified 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical
assay [18] provided a second measure of free radical scaveng-
ing activity. Ascorbic acid (0–60 μM), quercetin (0–60 μM),
or extract (0–1,000 mg/mL) dissolved in methanol was com-
bined with 100 μM DPPH and allowed to stand at RT for
10 min before we measured absorbance at 517 nm using a
Beckman DU 640 spectrophotometer. EC50, the concentration
of extract (μg/mL) or positive control (μM) required to scav-
enge 50 % of radicals, was determined by linear regression
analyses (n=4) with relative scavenging capacity expressed as
% ascorbic acid equivalents (% AAE=[(EC50)ascorbic acid/
(EC50)treatment]×100%.
Statistical Analyses Results are expressed as means ±
SEM. Pearson’s correlation analyses were used to inves-
tigate relationships between TPH, TMAC, antiglycation
and radical scavenging activities, using Log-transformed
data, as required. Correlation coefficients, coefficients of
determination (r 2 ) and P-value estimates were calculated
using S-Plus 8.0 statistical software (Insightful Corp.,
Seattle, WA).
Table 1 List of sampled berry species with collection details and extraction data
Species Family Common name Source a Colour % water b % yield c
Arctous alpinaL. Ericaceae Black bearberry 1 Dark purple 79.5 35.6
Cornus canadensis L. Cornaceae Bunchberry 2 Red 89 48.8
Empetrum nigrumL. Ericaceae Crowberry 2 Dark purple 86 42.1
Juniperus communis L. Pinaceae Common juniper 2 Blue 68 47.2
Ribes glandulosumGrauer Grossulariaceae Swamp currant 2 Red 78.5 64.8
Ribes triste Pall. Grossulariaceae Smooth currant 2 Red 76 43.5
Rubus chamaemorus L. Rosaceae Cloudberry 1 Orange 84 62.7
Sorbus decora (Sarg.) CK Schneid. Rosaceae Showy mountain ash 2 Orange-red 81 72.8
Vaccinium angustifoliumAit. Ericaceae Lowbush blueberry 3 Blue 85 74.1
Vaccinium oxycoccusL. Ericaceae Bog cranberry 4 Red 77.5 44.0
Vaccinium uliginosum L. (A) Ericaceae Bog bilberry 1 Blue 84.5 73.3
V. uliginosum L. (B) Ericaceae 2 Blue 85.5 76.0
V. uliginosum L. (C) Ericaceae 2 Dark purple 87 78.1
Vaccinium vitis-idaeaL. Ericaceae Lingonberry 4 Crimson 85 79.2
a Berry samples were collected in August and September near: 1) Kuujuac, Québec, Canada; 2) Great Whale River, Québec, Canada; 3) La Vérendrye
Wildlife Reserve, Québec, Canada; 4) Chibougamau, Québec, Canada
b Percent water of berry samples is expressed as [1−(g dry wt/g fresh wt)]×100%
c Percent yield is expressed as (g extract/g dry wt)×100%
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Results
Fourteen samples representing 12 species are detailed in
Table 1. Three samples of V. uliginosum were included to
gauge potential intra-species variation. Water content was
over 75 % for all berries except J. communis, a modified cone
more frequently used for medicine than food. Extraction
yields varied from 36 to 79 % of dry weight (Table 1).
Inhibition of Non-Enzymatic Formation of AGEs Fluorometric
analyses of AGEs revealed concentration-dependent inhibi-
tion by all extracts but with varying potencies (Fig. 1a).
Whereas most IC50 values were above 50 μg/mL, those of
five extracts (J. communis, A. alpina, E. nigrum, V. vitis-idaea,
and R. glandulosum) were approximately 100-fold lower than
the weakest inhibitor, R. chamaemorus (Table 2). Quercetin, a
commonly occurring flavonoid with established AGE
inhibiting activity, exhibited an IC50 of 6.1 μMwhile ascorbic
acid elicited no effect at the tested concentrations
(0.2–200 μM). Immunochemically detected CML-BSA ad-
ducts in vehicle-control samples (with BSA+glucose/fruc-
tose) established the uninhibited level of glycation (100 %),
vehicle with BSA alone yielded no adducts, and quercetin
(16 μM) reduced adduction by over 80 % (Fig. 1b). All
extracts inhibited CML-BSA adduct formation in a
concentration-dependent manner (data not shown) with rela-
tive activities (at 50 μg/mL) illustrated in Fig. 1b. Percent
inhibition relative to the vehicle-controls ranged from 37 %
Fig. 1 Inhibition of AGE formation by representative berry extracts and
correlations with phenolic and anthocyanin content as well as radical
scavenging activity. a Concentration-dependent inhibition of fluorescent
AGE formation by various extracts (mean ± SEM, n=3–4). Correspond-
ing IC50 values are listed in Table 2. bWestern blot using CML-specific
antibodies on protein samples incubated with glucose/fructose, vehicle,
and quercetin (positive control, 16 μM), or 50 μg of berry extract. BSA
incubated without sugar was used as a negative control for the CML-BSA
antibody. Each SDS-PAGE separation was performed in duplicate; the
first was used for Western blotting (upper panels) and the second to
control for protein loading (Coomassie Blue staining – lower panels). c-
f Pearson’s correlation analyses of fluorescent AGE (fluor-AGE) and
carboxymethyl lysine (CML) inhibition relative to total phenolic content
(TPH, expressed as quercetin equivalents), total monomeric anthocyanin
content (TMAC, expressed as cyanidin-3-glucoside equivalents), oxygen
radical absorbance capacity (ORAC, expressed as Trolox equivalents),
and 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activity
expressed as percent ascorbic acid equivalents (% AAE). [(c) fluor-
AGE vs. TPH: p<0.001; r2=0.760; CML vs TPH: p=0.001; r2=0.594;
(d) fluor-AGE vs. TMAC: p=0.097; r2=0.213; CML vs TMAC: p=
0.047; r2=0.291; (e) fluor-AGE vs. Trolox eq: p<0.001; r2=0.928;
CML vs Trolox eq: p=0.002; r2=0.578; (f) fluorAGE vs. %AAE:
p<0.008; r2=0.452; CML vs %AAE: p=0.059; r2=0.266]
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for R. chamaemorus to 77 % for E. nigrum (Table 2) and
correlated highly with IC50 values obtained in the fluores-
cence assay (p<0.001; r2=0.651).
J. communis, A. alpina, and E. nigrum extracts and lowest in
S. decora, V. angustifolium and R. chamaemorus, extracts
(Table 2). TMAC, a subclass of phenolics, was expectedly
lower than TPH in all extracts and was highest in Ericaceous
berries (with the exception of V. oxycoccus). No correlation,
however, was observed between the two measures.
Radical Scavenging Activity Extracts of J. communis,
E. nigrum, and R. glandulosum generated the strongest scav-
enging effects with ORAC values over 2,000 μM Trolox
equivalents (TE). In contrast, the TE of six extracts
(C. canadensis, R. triste, R. chamaemorus, S. decora, V.
angustifolium and V. oxycoccus) was below 700 μM (Table 2).
Whereas the activity of ascorbic acid and the most potent
extract (J. communis) were similar, that of quercetin was 20-
times greater. In the DPPH assay, a similar 10-fold difference
in activity was observed between the strongest and weakest
radical scavenging extracts. Quercetin (EC50=12.3±0.8 μM,
205 % AAE) was twice as effective as ascorbic acid (EC50=
25.4±1.2 μM) with extracts of A. alpina (78 % AAE),
J. communis (51 % AAE) and E. nigrum (43 % AAE) dem-
onstrating the most potent activities among berry samples
(Table 2). Extracts of S. decora and the four species of
Vaccinium demonstrated much weaker activity (<15 %
AAE). ORAC and DPPH results were significantly correlated
(p=0.028; r2=0.342).
Correlations Between Biochemical Activities and Phenolic or
Anthocyanin Content Pearson’s correlation analyses detected
several significant, positive relationships among the investi-
gated variables (Fig. 1). TPH was highly correlated with all
measures of antiglycation and radical scavenging activity but
correlations between TMAC and AGE inhibition were less
pronounced, only significant in relation to CML-BSA adducts
(Fig. 1c-d). Inhibition of AGE formation, particularly fluores-
cent AGEs, was strongly correlated with ORAC scores
Table 2 Antiglycation activities, total phenolic and total anthocyanin contents, and radical scavenging activities of berry extracts
Treatment AGE inhibition Phenolic & anthocyanin content Anti-oxidant activity
Fluorescent AGE - IC50
a CML-BSA % inhibition b TPH c (mg/g) TMAC d (mg/g) ORAC e Trolox eq. DPPH f % AAE
Quercetin 6.1±1.8 81.4±5.6 – – 91845±9437 205±13.3
Ascorbic acid No effect – – – 3669±274 100±4.7
A. alpine 35.6±9.5 62.6±82.0 71.9±3.1 2.91±0.20 1660±136 75.4±8.9
C. canadensis 120.3±6.9 54.6±4.0 19.2±4.2 1.93±0.03 624±38 19.4±2.2
E. nigrum 38.2±2.5 76.7±7.2 70.0±5.7 23.27±1.37 2247±225 40.2±6.9
J. communis 27.4±2.6 64.9±4.4 99.2±4.7 0.47±0.07 3876±142 48.6±2.3
R. glandulosum 46.0±4.2 59.4±5.0 45.4±6.5 1.17±0.12 2182±109 16.8±2.5
R. triste 208.6±34.4 53.0±4.4 34.2±7.7 0.36±0.15 510±34 22.8±5.7
R. chamaemorus 4009±1753 37.4±14.8 13.2±2.3 0.02±0.01 438±57 19.4±1.9
S. decora 192.7±37.1 52.6±1.5 10.3±1.7 0.05±0.01 657±88 10.8±1.7
V. angustifolium 177.8±22.4 39.0±3.7 12.4±2.1 6.81±0.50 732±38 9.5±1.6
V. oxycoccus 60.2±1.5 60.9±4.1 19.8±3.1 0.50±0.13 1049±260 7.7±0.7
V. uliginosum (A) 75.5±14.7 53.6±3.9 14.9±1.9 2.27±0.03 747±29 8.0±0.7
V. uliginosum (B) 57.5±14.6 61.5±7.1 29.8±5.1 8.55±0.32 1075±132 13.8±2.2
V. uliginosum (C) 57.8±8.2 61.4±4.4 26.3±6.4 9.07±0.35 1216±112 15.3±3.2
V. vitis-idaea 44.5±12.4 62.1±4.7 32.6±2.2 9.84±0.37 1725±66 8.1±0.8
a IC50 concentrations ± SEM calculated as the extract (μg/mL) or control (μM) concentration required to reduce fluorescent AGE formation by 50 % as
determined by regression analysis (n=3–4)
b% inhibition ± SEM of Nε-(carboxymethyl)lysine-BSA (CML-BSA) adduct formation as determined by densitometry of Western blot analyses of
purified protein following treatment with sugar, vehicle, 16 μM quercetin or 50 μg extract/mL (n=4–5)
c Total phenolic content (TPH) as determined by the Folin-Ciocalteu method, expressed as mg quercetin equivalents/g extract ± SEM (n=3–4)
d Total monomeric anthocyanin content (TMAC) as determined by the acid differential method, expressed as mg cyaniding-3-glucoside equivalents/g
extract ± SEM (n=3–4)
e Oxygen radical absorbance capacity (ORAC) is expressed in μM Trolox equivalents ± SEM at a concentration of 1 mg/mL for extracts and 1 mM for
quercetin and ascorbic acid (n=4–5)
f Percent ascorbic acid equivalents (% AAE) as determined by the 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging assay (n=4–5)
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Total Phenolic and Anthocyanin Content TPH ranged from 10
to 100 mg quercein equivalents per g extract, highest in
(Fig. 1e) while DPPH radical scavenging correlated less ro-
bustly with fluorescent AGE formation and insignificantly
with CML-BSA adduction (Fig. 1f).
Discussion
Within this collection of Canadian berry extracts,
antiglycation activity correlates strongly with radical scaveng-
ing activity and total phenolic content as well as weakly with
total anthocyanin content. Given that the AGE-inhibiting ef-
fects of other small fruits –muscadine grape [17], lingonberry
[16] and acerola [21] – have been attributed to phenolic
metabolites including but not limited to anthocyanins, this
finding is not surprising. As such, while anthocyanins are
effective AGE inhibitors contributing to activity, TPH appears
more pertinent than TMAC to antiglycation (and radical scav-
enging) activity, in general.
Inhibition of AGE formation correlated more strongly with
ORAC data than with those for DPPH scavenging, likely
reflecting the greater involvement of peroxyl- over DPPH-
like radicals in glycation reactions and/or inhibitory mecha-
nisms. The relative activities of quercetin and ascorbic acid –
both commonly found in berries – provide additional insight
since 1) quercetin was 20 times more effective than ascorbic
acid in the ORAC assay but only twice so in the DPPH assay,
and 2) quercetin potently inhibits AGE formation while ascor-
bic acid had no effect in our system (and enhances glycaton in
others [22]). Apparently, not all antioxidants prevent
glycation. Moreover, antiglycation activity is determined by
more than antioxidant properties. Indeed, studies on individ-
ual plant phenolics report distinct structural determinants of
antioxidant and antiglycation activity [11,23].
Of the three samples of V. uliginosum, the two James Bay
collections (B & C) yielded nearly identical results in all
assays. Sample A, collected in the far north, however,
contained fewer phenolics and anthocyanins and displayed
correspondingly weaker activities, highlighting the impact of
intra-species variation. Because berry composition depends
on genetic, developmental, seasonal, ecological and posthar-
vest factors, the precise activities and rankings reported here
are specific to the collected samples. However, as similar
correlations between phenolics, radical scavenging, and
AGE inhibition are found among medicinal plants of Canada
[18] and Thailand [24], the identified relationships likely
extend to other collections of berries and phenolic-
containing plant foods.
Whereas the extract concentrations required to significantly
reduce AGE formation exceeded 10 μg/mL, often by an order
of magnitude, individual phenolics are active at concentra-
tions below 1 μg/mL [18]. Despite low bioavailability
resulting from poor absorption and rapid metabolic
breakdown, plasma levels of food-derived phenolics can reach
low μM concentrations [25]. Consumption of berries in-
creases circulating levels of intact phenolics as well as their
metabolites [26], some of which retain their antiglycation
activity [27]. Increasing consumption of berries, particularly
phenolic-rich species such as E. nigrum and A. alpina, may
thus aid in the prevention and management of AGE-related
conditions like diabetes and associated complications. Given
that this is the first study to explore antiglycation relationships
within a collection of plant-based foods, our results set the
stage for future antiglycation research of phenolics and their
human and microbial metabolites in cells, animals, or humans.
In northern Québec, access to fresh fruits and vegetables is
limited and expensive when available. Whereas other wild
fruits are scarce, berries are plentiful and contribute valuably
to the traditional diet of the region’s indigenous communities,
which, like many others around the world, suffer increased
risk of diabetes and diabetic complications [28,29].
Representing a culturally relevant and locally accessible
source of needed nutrients and plant phenolics, berries warrant
continued investigation as dietary means of improving aborig-
inal health.
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